51ÉçÇø

CAPABILITY | ECOLOGICAL & BIOLOGICAL SCIENCES

Environmental Risk Assessment for Pharmaceuticals & Veterinary Products

Various pharmaceuticals

Full-cycle environmental exposure and risk assessments

Gaining regulatory approval and meeting product defense requirements for pharmaceutical and veterinary products has become increasingly complex in the U.S. and EU. 51ÉçÇø conducts environmental risk assessments for pharmaceuticals and veterinary products to evaluate fate and transport properties and develop potential exposure scenarios.

How does 51ÉçÇø help clients assess the environmental impact of their pharmaceutical and veterinary products?

For decades, 51ÉçÇø has helped clients with complex issues involving nanotechnology, endocrine disruptors, biologicals, genetically modified organisms, and traditional human and veterinary pharmaceuticals.

Our environmental toxicologists and regulatory specialists are involved in the global dialogue surrounding the detection of trace concentrations of pharmaceuticals in surface water, wastewater, and drinking water and the related issues of potential treatment, risk, and regulation. Our assessments range from simple justifications for categorical exclusion to complex multi-parameter, multi-receptor watershed-scale risk assessments.

51ÉçÇø delivers support at all phases:

  • Initial strategy development
  • Placement and monitoring of studies
  • Preparation of the environmental assessment
  • Regulatory submission and negotiations